Harold Selick

Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.

Part of GSK Plc, Affymax Research Institute is a private company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001.

Camitro Corporation is a drug discovery technology development company based in Menlo Park, California. Camitro is dedicated to the development and application of innovative computational technologies for the design, selection and optimization of novel drug candidates. The Company's predictive models enable scientists to assess ADMET properties of chemical compounds throughout the discovery process, from the earliest stages of compound selection and library design through lead candidate evaluation and re-design. Its integrated platform of models permits the optimization of multiple ADMET properties simultaneously, at high throughput, based upon chemical structure alone

Part of Galapagos NV, ArQule UK Ltd. is a private company that discovers and produces novel chemical compounds with commercial potential. ArQule UK Ltd. is based in Cambridge, UK. ArQule was acquired by Galapagos Biotech Ltd., a subsidiary of Galapagos NV from ArQule, Inc. on June 23, 2003. The British company was founded by Harold E. Selick.

PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV.

Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA.

Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.

Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.

Part of Merck & Co., Inc., Camitro UK Ltd. is a private company that operates commercial research institutions. The company is based in Cambridge, UK. The British company was founded by Harold E. Selick.

Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA.

Hinge Bio, Inc. is a holding company, which engages in the development of specific and multi-specific antibodies. The company is headquartered in Burlingame, CA.

Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX.